Company registration number 14840363 (England and Wales)
Broadcastmed Limited
financial statements
For the period ended 31 December 2024
Broadcastmed Limited
Contents
Page
Statement of financial position
1
Statement of changes in equity
2
Notes to the financial statements
3 - 5
Broadcastmed Limited
Statement of financial position
As at 31 December 2024
31 December 2024
- 1 -
31 December 2024
31 May 2024
Notes
£
£
£
£
Fixed assets
Investments
3
11,665,112
11,665,112
Current assets
-
-
Creditors: amounts falling due within one year
4
(11,669,911)
(11,667,511)
Net current liabilities
(11,669,911)
(11,667,511)
Net liabilities
(4,799)
(2,399)
Capital and reserves
Called up share capital
1
1
Profit and loss reserves
(4,800)
(2,400)
Total equity
(4,799)
(2,399)
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The directors of the company have elected not to include a copy of the income statement within the financial statements.true
The financial statements were approved by the board of directors and authorised for issue on 13 November 2025 and are signed on its behalf by:
Mrs Jennifer Tapper
Director
Company registration number 14840363 (England and Wales)
Broadcastmed Limited
Statement of changes in equity
For the period ended 31 December 2024
- 2 -
Share capital
Profit and loss reserves
Total
Notes
£
£
£
Balance at 2 May 2023
-
Period ended 31 May 2024:
Loss and total comprehensive income
-
(2,400)
(2,400)
Issue of share capital
1
-
1
Balance at 31 May 2024
1
(2,400)
(2,399)
Period ended 31 December 2024:
Loss and total comprehensive income
-
(2,400)
(2,400)
Balance at 31 December 2024
1
(4,800)
(4,799)
Broadcastmed Limited
Notes to the financial statements
For the period ended 31 December 2024
- 3 -
1
Accounting policies
Company information
Broadcastmed Limited is a private company limited by shares incorporated in England and Wales. The registered office is 1st Floor 8 Bridle Close, Kingston Upon Thames, United Kingdom, KT1 2JW.
1.1
Basis of preparation
These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.
The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.
The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.
The company has taken advantage of the exemption under section 399 of the Companies Act 2006 not to prepare consolidated accounts, on the basis that the group of which this is the parent qualifies as a small group. The financial statements present information about the company as an individual entity and not about its group.
Broadcastmed Limited is a wholly owned subsidiary of BroadcastMed Holdco LLC, its ultimate parent undertaking. The results of Broadcastmed Limited are included in the consolidated financial statements of BroadcastMed Holdco, LLC which are available from 400 N.Ashley Dr, Ste 2600, Tampa, FL, 33602.
Related party exemption
The company has taken advantage of exemption, under the terms of Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland', not to disclose related party transactions with other group entities where the relationship is one of being wholly owned.
1.2
Fixed asset investments
Interests in subsidiaries are initially measured at cost and subsequently measured at cost less any accumulated impairment losses. The investments are assessed for impairment at each reporting date and any impairment losses or reversals of impairment losses are recognised immediately in profit or loss.
A subsidiary is an entity controlled by the company. Control is the power to govern the financial and operating policies of the entity so as to obtain benefits from its activities.
1.3
Financial instruments
The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.
Financial instruments are recognised in the company's statement of financial position when the company becomes party to the contractual provisions of the instrument.
Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.
Broadcastmed Limited
Notes to the financial statements (continued)
For the period ended 31 December 2024
1
Accounting policies
(Continued)
- 4 -
Classification of financial liabilities
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.
Basic financial liabilities
Basic financial liabilities, including creditors and loans from fellow group, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.
1.4
Equity instruments
Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.
2
Employees
The average monthly number of persons (including directors) employed by the company during the period was:
2024
2024
Number
Number
Total
0
0
3
Fixed asset investments
2024
2024
£
£
Shares in group undertakings and participating interests
11,665,112
11,665,112
4
Creditors: amounts falling due within one year
2024
2024
£
£
Amounts owed to group undertakings
11,665,111
11,665,111
Other creditors
4,800
2,400
11,669,911
11,667,511
Broadcastmed Limited
Notes to the financial statements (continued)
For the period ended 31 December 2024
- 5 -
5
Audit report information
As the income statement has been omitted from the filing copy of the financial statements, the following information in relation to the audit report on the statutory financial statements is provided in accordance with s444(5B) of the Companies Act 2006.
The auditor's report is qualified and the auditor reported as follows:
Qualified opinion on financial statements
We have audited the financial statements of Broadcastmed Limited (the 'company') for the period ended 31 December 2024 which comprise the statement of financial position, the statement of changes in equity and notes to the financial statements, including significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accounting Practice).
In our opinion, except for the effects of the matter described in the Basis for Qualified Opinion paragraph, the financial statements:
give a true and fair view of the state of the company's affairs as at 31 December 2024 and of its loss for the period then ended;
have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and
have been prepared in accordance with the requirements of the Companies Act 2006.
Basis for qualified qualified opinion
The company's investments are carried in the Statement of Financial Position at a cost of £11,665,112. FRS102 states that investments should be carried at cost less any impairment. The directors have considered the carrying value of the investment based on a multiple of adjusted EBITDA and do not believe there is any impairment of the investment. Observable market data based on company size, business sector and location suggests that the multiple used is overstated and that a material impairment exists. Depending on the multiple used the impairment could range from £5.4m to £8.4m. Had an impairment been recognised in the financial statements, the net loss for the year would have been increased, and the investment value and net asset position would have been decreased by the amount of the impairment.
We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor's responsibilities for the audit of the financial statements section of our report. We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our qualified opinion.
Senior Statutory Auditor:
Gary Chadwick FCCA
Statutory Auditor:
DJH Audit Limited
Date of audit report:
23 December 2025
6
Parent company
The smallest and largest group in which the results of the company are consolidated is that headed by BroadcastMed Holdco, LLC. Consolidated accounts are available from 400 N.Ashley Dr, Ste 2600, Tampa, FL, 33602